Literature DB >> 24108702

Specific splice variants are associated with Parkinson's disease.

Jose A Santiago1, Clemens R Scherzer, Judith A Potashkin.   

Abstract

BACKGROUND: Diagnosis of Parkinson's disease (PD) currently relies on assessment of motor symptoms. Recently, sensitive, specific, and readily available splice variant-specific biomarkers were identified in peripheral blood from participants in the Diagnostic and Prognostic Biomarkers in Parkinson Disease study.
METHODS: Here we test for an association between candidate splice variant biomarkers and PD in blood of an independent population of cases and controls nested in the Harvard NeuroDiscovery Center Biomarker Study.
RESULTS: Expression of 7 out of 13 candidate biomarkers was dysregulated in whole cellular blood of patients with PD.
CONCLUSIONS: These results support the view that differential expression of a subset of splice-variant markers in blood is associated with PD. Further evaluation in untreated, de novo patients and at-risk subjects is warranted.
© 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; biomarker; gene expression; neurodegeneration; splicing

Mesh:

Substances:

Year:  2013        PMID: 24108702      PMCID: PMC3812386          DOI: 10.1002/mds.25635

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Authors:  Bin Zheng; Zhixiang Liao; Joseph J Locascio; Kristen A Lesniak; Sarah S Roderick; Marla L Watt; Aron C Eklund; Yanli Zhang-James; Peter D Kim; Michael A Hauser; Edna Grünblatt; Linda B Moran; Silvia A Mandel; Peter Riederer; Renee M Miller; Howard J Federoff; Ullrich Wüllner; Spyridon Papapetropoulos; Moussa B Youdim; Ippolita Cantuti-Castelvetri; Anne B Young; Jeffery M Vance; Richard L Davis; John C Hedreen; Charles H Adler; Thomas G Beach; Manuel B Graeber; Frank A Middleton; Jean-Christophe Rochet; Clemens R Scherzer
Journal:  Sci Transl Med       Date:  2010-10-06       Impact factor: 17.956

2.  Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Authors:  Hongliu Ding; Alison K Sarokhan; Sarah S Roderick; Rachit Bakshi; Nancy E Maher; Paymon Ashourian; Caroline G Kan; Sunny Chang; Andrea Santarlasci; Kyleen E Swords; Bernard M Ravina; Michael T Hayes; U Shivraj Sohur; Anne-Marie Wills; Alice W Flaherty; Vivek K Unni; Albert Y Hung; Dennis J Selkoe; Michael A Schwarzschild; Michael G Schlossmacher; Lewis R Sudarsky; John H Growdon; Adrian J Ivinson; Bradley T Hyman; Clemens R Scherzer
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

Review 3.  Shared dysregulated pathways lead to Parkinson's disease and diabetes.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Trends Mol Med       Date:  2013-01-31       Impact factor: 11.951

4.  Molecular markers of early Parkinson's disease based on gene expression in blood.

Authors:  Clemens R Scherzer; Aron C Eklund; Lee J Morse; Zhixiang Liao; Joseph J Locascio; Daniel Fefer; Michael A Schwarzschild; Michael G Schlossmacher; Michael A Hauser; Jeffery M Vance; Lewis R Sudarsky; David G Standaert; John H Growdon; Roderick V Jensen; Steven R Gullans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

5.  Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.

Authors:  Anja Jaeschke; Mercedes Rincón; Beth Doran; Judith Reilly; Donna Neuberg; Dale L Greiner; Leonard D Shultz; Aldo A Rossini; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

6.  Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes.

Authors:  Lilach Soreq; Hagai Bergman; Zvi Israel; Hermona Soreq
Journal:  Neurodegener Dis       Date:  2011-12-09       Impact factor: 2.977

7.  The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity.

Authors:  David A Buchner; Jon M Geisinger; Patricia A Glazebrook; Michael G Morgan; Sabrina H Spiezio; Karl J Kaiyala; Michael W Schwartz; Takeshi Sakurai; Andrew J Furley; Diana L Kunze; Colleen M Croniger; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2012-07-01       Impact factor: 2.957

8.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function.

Authors:  David Warde-Farley; Sylva L Donaldson; Ovi Comes; Khalid Zuberi; Rashad Badrawi; Pauline Chao; Max Franz; Chris Grouios; Farzana Kazi; Christian Tannus Lopes; Anson Maitland; Sara Mostafavi; Jason Montojo; Quentin Shao; George Wright; Gary D Bader; Quaid Morris
Journal:  Nucleic Acids Res       Date:  2010-07       Impact factor: 16.971

9.  PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.

Authors:  Nicoletta Schintu; Lucia Frau; Marcello Ibba; Pierluigi Caboni; Arianna Garau; Ezio Carboni; Anna R Carta
Journal:  Eur J Neurosci       Date:  2009-02-24       Impact factor: 3.386

10.  A molecular signature in blood identifies early Parkinson's disease.

Authors:  Leonid Molochnikov; Jose M Rabey; Evgenya Dobronevsky; Ubaldo Bonucelli; Roberto Ceravolo; Daniela Frosini; Edna Grünblatt; Peter Riederer; Christian Jacob; Judith Aharon-Peretz; Yulia Bashenko; Moussa B H Youdim; Silvia A Mandel
Journal:  Mol Neurodegener       Date:  2012-05-31       Impact factor: 14.195

View more
  12 in total

1.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

Review 3.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

4.  Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.

Authors:  Jose A Santiago; Clemens R Scherzer; Judith A Potashkin
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 5.  Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Diagnostics (Basel)       Date:  2014-10-22

6.  Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases.

Authors:  Rasmus Rydbirk; Jonas Folke; Kristian Winge; Susana Aznar; Bente Pakkenberg; Tomasz Brudek
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

7.  Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.

Authors:  Jose A Santiago; Alyssa M Littlefield; Judith A Potashkin
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

8.  Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

9.  Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2018-05-29       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.